Nkarta (NKTX) Operating Leases (2019 - 2026)
Nkarta (NKTX) posted quarterly Operating Leases of $67.9 million for Q1 2026, down 6.91% year-over-year from $73.0 million in Q1 2025, and down 2.32% quarter-over-quarter from $69.5 million in Q4 2025.
Nkarta (NKTX) Operating Leases (2019 - 2026) Analysis & Trends
Nkarta's Operating Leases history runs 8 years deep, the most recent figure standing at $67.9 million for Q1 2026.
- In Q1 2026, Operating Leases fell 6.91% year-over-year to $67.9 million; the TTM figure through Mar 2026 stood at $67.9 million (down 6.91% YoY), while the FY2025 annual figure was $69.5 million, down 6.32% from the prior year.
- Operating Leases for Q1 2026 stood at $67.9 million, down from $69.5 million in the prior quarter.
- The five-year high for Operating Leases was $85.5 million in Q1 2023, with the low at $66.7 million in Q1 2022.
- The 5-year median for Operating Leases is $78.1 million (2022), against an average of $76.2 million.
- The sharpest annual moves came in 2022 and 2025: Operating Leases soared 688.82% in 2022, then slipped 10.72% in 2025.
- Nkarta's Operating Leases stood at $78.7 million in 2022, then increased by 4.56% to $82.3 million in 2023, then dropped by 9.78% to $74.2 million in 2024, then dropped by 6.32% to $69.5 million in 2025, then declined by 2.32% to $67.9 million in 2026.
- Business Quant data shows NKTX's Operating Leases at $67.9 million in Q1 2026, $69.5 million in Q4 2025, and $70.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.26 Mn |
| Mar 31, 2026 | 67.92 Mn |
| Dec 31, 2025 | 69.53 Mn |
| Sep 30, 2025 | 70.26 Mn |
| Jun 30, 2025 | 71.63 Mn |
| Mar 31, 2025 | 72.96 Mn |
| Dec 31, 2024 | 74.22 Mn |
| Sep 30, 2024 | 78.69 Mn |
| Jun 30, 2024 | 80.04 Mn |
| Mar 31, 2024 | 81.10 Mn |
| Dec 31, 2023 | 82.27 Mn |
| Sep 30, 2023 | 83.41 Mn |
| Jun 30, 2023 | 84.45 Mn |
| Mar 31, 2023 | 85.54 Mn |
| Dec 31, 2022 | 78.69 Mn |
| Sep 30, 2022 | 78.11 Mn |
| Jun 30, 2022 | 69.41 Mn |
| Mar 31, 2022 | 66.74 Mn |
| Dec 31, 2021 | 9.98 Mn |
| Sep 30, 2021 | 10.35 Mn |